Behind The Knife: The Surgery Podcast27 Juli

Clinical Challenges in Breast Surgery: The Fundamentals of Cancer Immunotherapy

Immune checkpoint inhibitors have rapidly reshaped care for triple-negative breast cancer (TNBC)—but surgical teams increasingly encounter their downstream perioperative consequences. In this episode, we define immunotherapy through the lens of checkpoint biology, review the landmark evidence supporting pembrolizumab in metastatic PD‑L1–positive TNBC (KEYNOTE‑355) and curative-intent stage II–III TNBC (KEYNOTE‑522), and translate immune-related adverse events (irAEs) into practical periop recognition, triage, and timing decisions—especially for endocrine, pulmonary, hepatic, dermatologic, and GI toxicities.

Hosts:
- Rashmi Kumar, MD, PhD
Resident, University of Michigan General Surgery Residency Program
Twitter/X: @RashmiJKumar
- Melissa Pilewskie, MD
Attending Breast Surgical Oncologist, Co-Director of the Weiser Family Center for Breast Cancer, Michigan Medicine
Twitter/X: @MPilewskie
- Stephanie Downs-Canner, MD
Attending Breast Surgical Oncologist & Physician-Scientist, Memorial Sloan Kettering Cancer Center, Program Director of the Breast Surgical Oncology Fellowship Training Program
Twitter/X: @SDownsCanner

Learning Objectives:

Define immunotherapy and immune checkpoint inhibition in breast cancer
Summarize current clinical indications and pivotal evidence for pembrolizumab in TNBC
Equip perioperative clinicians to identify and manage immune-related adverse events (irAEs) or side effects of immunotherapy.

Rationale for Immunotherapy in Breast Cancer Review

Selecting Triple Negative Breast Cancer Patients for Immunotherapy: https://pubmed.ncbi.nlm.nih.gov/37714640/

Landmark Clinical Trials Discussed in this Episode

KEYNOTE-355: https://pubmed.ncbi.nlm.nih.gov/33232653/
KEYNOTE-522: https://pubmed.ncbi.nlm.nih.gov/33232642/
IMpassion130: https://pubmed.ncbi.nlm.nih.gov/30345906/
IMpassion131: https://pubmed.ncbi.nlm.nih.gov/33930478/

Assessment of Surgical Outcomes in patients receiving chemoimmunotherapy

Surgical outcomes after neoadjuvant chemoimmunotherapy in triple-negative breast cancer: https://pubmed.ncbi.nlm.nih.gov/38332314/

Immune Related Adverse Events and Management

Schneider BJ, et al. Management of immune-related adverse events: https://pubmed.ncbi.nlm.nih.gov/34724392/
Brahmer JR, et al. SITC clinical practice guideline: https://pubmed.ncbi.nlm.nih.gov/34177534/

Det här avsnittet är hämtat från ett öppet RSS-flöde och publiceras inte av Podme. Det kan innehålla reklam.

Avsnitt(500)

Journal Review in Hernia Surgery: What is Bioresorbable Mesh and Is It Worth It?

Join our OHSY Hernia team to review the current landscape of bioresorbable meshes and a conversation considering “are they worth it?"Hosts: Dr. Maggie Bosley - @MBosleyMD Dr. Sean Orenstein - @Orenst...

23 Juli 0s

Journal Review in Colorectal Surgery: ctDNA in Colorectal Cancer and Anal Squamous Cell Cancer

Circulating tumor DNA (ctDNA), a minimally invasive blood-based biomarker, has emerged as one of the most promising advances in cancer surveillance. Today, we will explore how ctDNA is transforming th...

20 Juli 41min

Mattox Conference Pro-Con Debate 2026: REBOA

Every spring for over 50 years, the Trauma, Critical Care, and Acute Care Surgery conference, best known simply as the MATTOX conference, is held in Las Vegas (https://www.trauma-criticalcare.com/). ...

17 Juli 28min

Mattox Conference Pro-Con Debate 2026: Management of Pediatric Pancreatic Injuries

16 Juli 26min

Wellbeing and Mental Health in Surgeons

Join us as we discuss research on mental health and wellbeing in the surgical workforce with Drs. Yang and Collins. The episode explores key findings from recent national surveys showing that nearly o...

13 Juli 41min

OBGYN Oral Board Review - Sample Episode: Intraoperative and Postoperative Wound

INTRODUCING Behind the Knife OBGYN Oral Board Review!The oral boards aren't just about knowledge—they are about executing under pressure. This course is designed to give you the structure and confiden...

9 Juli 23min

EPA Playbook: Blunt or Penetrating Trauma

Join Drs. Georgoff, Burke, and Premkumar in this episode of the EPA Playbook as they break down a practical, repeatable framework for managing patients in the trauma bay, one of the most high-pressure...

7 Juli 50min